Anti-TNFSF5/CD40L/CD154 Antibody (Toralizumab)
Catalog No.
F1082
Anti-TNFSF5/CD40L/CD154 Antibody (Toralizumab)
Featured Products
Toralizumab (IDEC-131) is a humanized monoclonal antibody (mAb) against CD40L (CD154) composed of a human gamma 1 heavy chain and a human kappa light chain. Toralizumab specifically binds to human CD40L on T cells, thereby preventing CD40 signaling. Toralizumab is an immunosuppressant with potential for use in active systemic lupus erythematosus (SLE) research.
145.66 kDa
Dry ice
252662-47-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IDEC-131, E6040
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P29965
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF5 / CD40L / CD154
Please avoid freeze-thaw cycles.